Interferon γ Regulates Acute and Latent Murine Cytomegalovirus Infection and Chronic Disease of the Great Vessels
Open Access
- 3 August 1998
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 188 (3) , 577-588
- https://doi.org/10.1084/jem.188.3.577
Abstract
To define immune mechanisms that regulate chronic and latent herpesvirus infection, we analyzed the role of interferon γ (IFN-γ) during murine cytomegalovirus (MCMV) infection. Lethality studies demonstrated a net protective role for IFN-γ, independent of IFN-α/β, during acute MCMV infection. Mice lacking the IFN-γ receptor (IFN-γR−/−) developed and maintained striking chronic aortic inflammation. Arteritis was associated with inclusion bodies and MCMV antigen in the aortic media. To understand how lack of IFN-γ responses could lead to chronic vascular disease, we evaluated the role of IFN-γ in MCMV latency. MCMV-infected IFN-γR−/− mice shed preformed infectious MCMV in spleen, peritoneal exudate cells, and salivary gland for up to 6 mo after infection, whereas the majority of congenic control animals cleared chronic productive infection. However, the IFN-γR was not required for establishment of latency. Using an in vitro explant reactivation model, we showed that IFN-γ reversibly inhibited MCMV reactivation from latency. This was at least partly explained by IFN-γ– mediated blockade of growth of low levels of MCMV in tissue explants. These in vivo and in vitro data suggest that IFN-γ regulation of reactivation from latency contributes to control of chronic vascular disease caused by MCMV. These studies are the first to demonstrate that a component of the immune system (IFN-γ) is necessary to regulate MCMV-associated elastic arteritis and latency in vivo and reactivation of a herpesvirus from latency in vitro. This provides a new model for analysis of the interrelationships among herpesvirus latency, the immune system, and chronic disease of the great vessels.Keywords
This publication has 89 references indexed in Scilit:
- Prior Infection with Cytomegalovirus Is Not a Major Risk Factor for Angiographically Demonstrated Coronary Artery AtherosclerosisThe Journal of Infectious Diseases, 1998
- Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines.Journal of Clinical Investigation, 1997
- Human Cytomegalovirus and Restenosis of the Internal Carotid ArteryStroke, 1996
- Association between Prior Cytomegalovirus Infection and the Risk of Restenosis after Coronary AtherectomyNew England Journal of Medicine, 1996
- Cytomegalovirus and atherosclerosisBioEssays, 1995
- Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantationJournal of Medical Virology, 1994
- Functional Role of Type I and Type II Interferons in Antiviral DefenseScience, 1994
- Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infectionThe American Journal of Cardiology, 1989
- Reduced mortality in murine cytomegalovirus infected mice following prophylactic murine interferon-γ treatmentAntiviral Research, 1988
- Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus.Journal of Clinical Investigation, 1982